Literature DB >> 33137225

Core-Modified Coelenterazine Luciferin Analogues: Synthesis and Chemiluminescence Properties.

Glwadys Gagnot1,2, Vincent Hervin1, Eloi P Coutant1, Sophie Goyard3, Yves Jacob4, Thierry Rose3, Fatima Ezzahra Hibti5, Alessia Quatela5, Yves L Janin1.   

Abstract

In this work on the design and studies of luciferins related to the blue-hued coelenterazine, the synthesis of heterocyclic analogues susceptible to produce a photon, possibly at a different wavelength, is undertaken. Here, the synthesis of O-acetylated derivatives of imidazo[1,2-b]pyridazin-3(5 H)-one, imidazo[2,1-f][1,2,4]triazin-7(1 H)-one, imidazo[1,2-a]pyridin-3-ol, imidazo[1,2-a]quinoxalin-1(5 H)-one, benzo[f]imidazo[1,2-a]quinoxalin-3(11 H)-one, imidazo[1',2':1,6]pyrazino[2,3-c]quinolin-3(11 H)-one, and 5,11-dihydro-3 H-chromeno[4,3-e]imidazo[1,2-a]pyrazin-3-one is described thanks to extensive use of the Buchwald-Hartwig N-arylation reaction. The acidic hydrolysis of these derivatives then gave solutions of the corresponding luciferin analogues, which were studied. Not too unexpectedly, even if these were "dressed" with substituents found in actual substrates of the nanoKAZ/NanoLuc luciferase, no bioluminescence was observed with these compounds. However, in a phosphate buffer, all produced a light signal, by chemiluminescence, with extensive variations in their respective intensity and this could be increased by adding a quaternary ammonium salt in the buffer. This aspect was actually instrumental to determine the emission spectra of many of these luciferin analogues.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  bioluminescence; chemiluminescence; homogeneous catalysis; luciferin; synthesis design

Year:  2020        PMID: 33137225     DOI: 10.1002/chem.202004311

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

1.  Comparative Investigation of the Chemiluminescent Properties of a Dibrominated Coelenterazine Analog.

Authors:  João Sousa; Carla M Magalhães; Patricia González-Berdullas; Joaquim C G Esteves da Silva; Luís Pinto da Silva
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.